Low-dose tirzepatide typically produces mild nausea, reduced appetite, or slight constipation in the first week or two
Some studies have found that reducing brain pressure through procedures like spinal taps provides sudden relief from migraines, indicating intracranial pressure might play a central role
Patients on dual therapy with metformin HCl 1500 mg/day and rosiglitazone 4 mg/day or with metformin HCl 1500 mg/day and pioglitazone 30 mg/day (switched to rosiglitazone 4 mg/day) entered a dose-stable run-in period of 6 weeks
These immunoregulatory effects are drug-specific and context-dependent
In conclusion, the effects of GLP-1Ra (i.e., semaglutide and liraglutide), including weight loss, slight BMD loss, and increased CTX, resembled to those observed with calorie restriction interventions [7, 9]
Meanwhile, 83% find products specifically marketed as supportive of people on GLP-1 medications appealing